PABPN1 and cancer: Given that PABPN1 is more likely to recognize and suppress the usage of weak proximal and non-canonical PASs in oculopharyngeal muscular dystrophy [10], we assessed whether PABPN1 diminishes the proximal PASs usage in cancer cells.